0 results for 'Juno Therapeutics'
Pharmaceutical Legal and Regulatory Trends To Watch in 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.Indian Law Blockbuster | $1.2 Billion Patent Denial | Judges, AKA Historians
The justices today hear the longest argument of this final week of the November argument session. We speak with Kathryn Fort, head of the ICWA appellate project at Michigan State University College of Law, the case.Mission Impossible? All-Star Lawyers Couldn't Convince Supreme Court in High-Stakes Case
Bristol-Myers Squibb had won a $1.2 billion judgment for infringement of its patent on a cancer treatment. But the justices left in place a Federal Circuit decision that invalidated the patent for failing to meet the Patent Act's written description requirement.'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket
The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case that originated in the Southern District of New York. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.View more book results for the query "Juno Therapeutics"
'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket
The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.Big Names Brandished in Effort to Restore $1.2B Cancer Treatment Verdict
The Federal Circuit ruled that a patent on a CAR-T treatment did not meet patent law's written description requirement. Jones Day and Irell & Manella are arguing for Bristol-Myers Squibb that the Federal Circuit has added judicial requirements to the statute that are virtually impossible for life sciences companies to meet.Tastes Like Invalidity—Judge Knocks Out Sweetener Patents, Despite PTAB Ruling
Judge James Selna ruled that PureCircle's patented methods of producing commercial grade Stevia are ineligible for patenting or fail on written description. That made winners of Sweegen and Sterne, Kessler, Goldstein & Fox.Intellectual Property Law in 2021: A Year of Surprises, COVID-Related and Otherwise
Waco jurors delivered a $2.175 billion shock. The Supreme Court crafted an unexpected remedy for PTAB appointments. And after 38 years, the Federal Circuit finally got its first Black judge.Women of Legal Tech: Emily Gaukstern on How a Robotic Wrist Brace Led to a Love of IP
Law student and biomedical engineer Emily Gaukstern talks adopting a "yes" mentality, what she'd say at dinner with Bill Belichick, and why it's important to have "uncomfortable" conversations on sexism.Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now